
Helvetica Chimica Acta p. 1618 - 1627 (2011)
Update date:2022-07-30
Topics:
Momeni, Badri Z.
Kazmi, Hoori
Najafi, Atefeh
Reactions of SnCl2 with the complexes cis-[PtCl 2(P2)] (P2=dppf (1,1′- bis(diphenylphosphino)ferrocene), dppp (1,3-bis(diphenylphosphino)propane=1, 1′-(propane-1,3-diyl)bis[1,1-diphenylphosphine]), dppb (1,4-bis(diphenylphosphino)butane=1,1′-(butane-1,4-diyl)bis[1, 1-diphenylphosphine]), and dpppe (1,5-bis(diphenylphosphino)pentane=1,1′- (pentane-1,5-diyl)bis[1,1-diphenylphosphine])) resulted in the insertion of SnCl2 into the Pt-Cl bond to afford the cis-[PtCl(SnCl 3)(P2)] complexes. However, the reaction of the complexes cis-[PtCl2(P2)] (P2=dppf, dppm (bis(diphenylphosphino)methane=1,1′-methylenebis[1,1-diphenylphosphine]), dppe (1,2-bis(diphenylphosphino)ethane=1,1′-(ethane-1,2-diyl)bis[1,1- diphenylphosphine]), dppp, dppb, and dpppe; P=Ph3P and (MeO) 3P) with SnX2 (X=Br or I) resulted in the halogen exchange to yield the complexes [PtX2(P2)]. In contrast, treatment of cis-[PtBr2(dppm)] with SnBr2 resulted in the insertion of SnBr2 into the Pt-Br bond to form cis-[Pt(SnBr3) 2(dppm)], and this product was in equilibrium with the starting complex cis-[PtBr2(dppm)]. Moreover, the reaction of cis-[PtCl 2(dppb)] with a mixture SnCl2/SnI2 in a 2 : 1 mol ratio resulted in the formation of cis-[PtI2(dppb)] as a consequence of the selective halogen-exchange reaction. 31P-NMR Data for all complexes are reported, and a correlation between the chemical shifts and the coupling constants was established for mono- and bis(trichlorostannyl) platinum complexes. The effect of the alkane chain length of the ligand and SnII halide is described. Copyright
View Morewebsite:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Chemsky(shanghai)International Co.,Ltd.
Contact:0
Address:0
Xiamen Goodhealth Pharmchem Co., Ltd.
Contact:0086-592-2097683
Address:404R No.2 54# Minzu Rd., Xiamen, China
Shanghai Norky Pharmaceutical Co., LTD.
website:http://www.norkypharm.com
Contact:86-21-61075300
Address:1165 Jiangning Road, Office 1502, Shanghai, China
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Doi:10.1021/acs.orglett.7b00710
(2017)Doi:10.1016/S0008-6215(97)00246-2
(1997)Doi:10.1039/j39680002756
(1968)Doi:10.1021/jm980114+
(1998)Doi:10.1002/jccs.200300016
(2003)Doi:10.1021/ja9809408
(1998)